Longitudinally extensive MRI lesions with gadolinium enhancement occur in more than just transverse myelitis.
Clinicians at a specialized transverse myelitis referral center reviewed the final diagnosis and clinical features for 457 patients referred for further evaluation and management. Only 54% were confirmed to be inflammatory (e.g., multiple sclerosis, neuromyelitis optica, rheumatologic); the remainder were 20% vascular (e.g., ischemia, arteriovenous malformation/fistula [AVM]), 8% spondylotic (degenerative, arthritic, compressive), and 18% other.
No single clinical, cerebrospinal fluid (CSF), or imaging characteristic differentiated the underlying causes with absolute certainty. Characteristics associated with inflammatory myelitis (IM) included younger age at onset, subacute presentation (48 hours to 21 days), and history of an autoimmune di…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)